- Home
- GNLN vs CNSP Comparison
GNLN vs CNSP Comparison
Compare GNLN & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLN
- CNSP
- Stock Information
- Founded
- GNLN 2005
- CNSP 2017
- Country
- GNLN United States
- CNSP United States
- Employees
- GNLN N/A
- CNSP N/A
- Industry
- GNLN Durable Goods
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- GNLN Consumer Discretionary
- CNSP Health Care
- Exchange
- GNLN Nasdaq
- CNSP Nasdaq
- Market Cap
- GNLN 5.8M
- CNSP 5.6M
- IPO Year
- GNLN 2019
- CNSP 2019
- Fundamental
- Price
- GNLN $0.01
- CNSP $1.04
- Analyst Decision
- GNLN
- CNSP Hold
- Analyst Count
- GNLN 0
- CNSP 1
- Target Price
- GNLN N/A
- CNSP N/A
- AVG Volume (30 Days)
- GNLN 290.1M
- CNSP 4.9M
- Earning Date
- GNLN 05-15-2025
- CNSP 06-17-2025
- Dividend Yield
- GNLN N/A
- CNSP N/A
- EPS Growth
- GNLN N/A
- CNSP N/A
- EPS
- GNLN N/A
- CNSP N/A
- Revenue
- GNLN $9,818,000.00
- CNSP N/A
- Revenue This Year
- GNLN $1,541.21
- CNSP N/A
- Revenue Next Year
- GNLN N/A
- CNSP N/A
- P/E Ratio
- GNLN N/A
- CNSP N/A
- Revenue Growth
- GNLN N/A
- CNSP N/A
- 52 Week Low
- GNLN $0.01
- CNSP $0.77
- 52 Week High
- GNLN $21.80
- CNSP $414.00
- Technical
- Relative Strength Index (RSI)
- GNLN 20.26
- CNSP 42.18
- Support Level
- GNLN $0.01
- CNSP $1.00
- Resistance Level
- GNLN $0.01
- CNSP $1.08
- Average True Range (ATR)
- GNLN 0.00
- CNSP 0.09
- MACD
- GNLN 0.01
- CNSP 0.00
- Stochastic Oscillator
- GNLN 20.00
- CNSP 19.05
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.